438 related articles for article (PubMed ID: 25908467)
21. Genetics of mineralocorticoid excess: an update for clinicians.
Zennaro MC; Rickard AJ; Boulkroun S
Eur J Endocrinol; 2013 Jul; 169(1):R15-25. PubMed ID: 23610123
[TBL] [Abstract][Full Text] [Related]
22. [Primary hyperaldosteronism with adrenal adenoma or hyperplasia: surgical case or not?].
Muller ME; Doenz F; Matter M; Wuerzner G; Burnier M
Rev Med Suisse; 2013 Sep; 9(397):1633-4, 1636-8. PubMed ID: 24073475
[TBL] [Abstract][Full Text] [Related]
23. [Endocrine hypertension].
Lehnert H; Scholz T; Schäfer M; Klose S
Dtsch Med Wochenschr; 2007 Feb; 132(5):207-17; quiz 219-20. PubMed ID: 17252364
[No Abstract] [Full Text] [Related]
24. Prediction of successful outcome in patients with primary aldosteronism.
Moo TA; Zarnegar R; Duh QY
Curr Treat Options Oncol; 2007 Aug; 8(4):314-21. PubMed ID: 18058076
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in diagnosis and treatment of primary aldosteronism.
Veglio F; Morello F; Rabbia F; Leotta G; Mulatero P
Minerva Med; 2003 Aug; 94(4):259-65. PubMed ID: 14605590
[TBL] [Abstract][Full Text] [Related]
26. A Late Diagnosis of Primary Aldosteronism.
Zorzi F; Olivieri O; Brazzarola P; Pizzolo F
High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):347-349. PubMed ID: 28293914
[TBL] [Abstract][Full Text] [Related]
27. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
Tomaschitz A; Ritz E; Pieske B; Rus-Machan J; Kienreich K; Verheyen N; Gaksch M; Grübler M; Fahrleitner-Pammer A; Mrak P; Toplak H; Kraigher-Krainer E; März W; Pilz S
Metabolism; 2014 Jan; 63(1):20-31. PubMed ID: 24095631
[TBL] [Abstract][Full Text] [Related]
28. [Aldosteroma (Conn's syndrome)].
Arabidze GG; Chikhladze NM
Kardiologiia; 1991 Dec; 31(12):90-5. PubMed ID: 1816452
[No Abstract] [Full Text] [Related]
29. Genetics of primary hyperaldosteronism.
Dutta RK; Söderkvist P; Gimm O
Endocr Relat Cancer; 2016 Oct; 23(10):R437-54. PubMed ID: 27485459
[TBL] [Abstract][Full Text] [Related]
30. Malignant hypertension in a patient with primary aldosteronism with elevated active renin concentration.
Oka K; Hayashi K; Nakazato T; Suzawa T; Fujiwara K; Saruta T
Intern Med; 1997 Oct; 36(10):700-4. PubMed ID: 9372330
[TBL] [Abstract][Full Text] [Related]
31. Secondary hypertension due to concomitant aldosterone-producing adenoma and parathyroid adenoma.
Chau K; Holmes D; Melck A; Chan-Yan C
Am J Hypertens; 2015 Feb; 28(2):280-2. PubMed ID: 24951725
[TBL] [Abstract][Full Text] [Related]
32. Aldosteronomas--state of the art.
McKenzie TJ; Lillegard JB; Young WF; Thompson GB
Surg Clin North Am; 2009 Oct; 89(5):1241-53. PubMed ID: 19836495
[TBL] [Abstract][Full Text] [Related]
33. [Resistant hypertension: a case report].
Bruno RM; Ghiadoni L; Mazzi V; Taddei S
Recenti Prog Med; 2010 Jan; 101(1):35-8. PubMed ID: 20391685
[TBL] [Abstract][Full Text] [Related]
34. Ventricular fibrillation: an extreme presentation of primary hyperaldosteronism.
Abdo A; Bebb RA; Wilkins GE
Can J Cardiol; 1999 Mar; 15(3):347-8. PubMed ID: 10202199
[TBL] [Abstract][Full Text] [Related]
35. [Therapy-resistant hypertension--the value of aldosterone antagonists].
Quack I; Reincke M; Rump LC
MMW Fortschr Med; 2007 Nov; 149(46):39-40. PubMed ID: 18069192
[TBL] [Abstract][Full Text] [Related]
36. Primary hyperparathyroidism with concurrent primary aldosteronism.
Maniero C; Fassina A; Guzzardo V; Lenzini L; Amadori G; Pelizzo MR; Gomez-Sanchez C; Rossi GP
Hypertension; 2011 Sep; 58(3):341-6. PubMed ID: 21825220
[No Abstract] [Full Text] [Related]
37. Worsening of lipid metabolism after successful treatment of primary aldosteronism.
Adolf C; Asbach E; Dietz AS; Lang K; Hahner S; Quinkler M; Rump LC; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Reincke M
Endocrine; 2016 Oct; 54(1):198-205. PubMed ID: 27179655
[TBL] [Abstract][Full Text] [Related]
38. Radiofrequency ablation treatment for aldosterone-producing adenomas.
Sacks BA; Sacks AC; Faintuch S
Curr Opin Endocrinol Diabetes Obes; 2017 Jun; 24(3):169-173. PubMed ID: 28248752
[TBL] [Abstract][Full Text] [Related]
39. [Primary hyperaldosteronism].
Chambaz IC; Pechère-Bertschi A
Rev Med Suisse; 2011 Sep; 7(308):1736-8, 1740-2. PubMed ID: 21954813
[TBL] [Abstract][Full Text] [Related]
40. Update in primary aldosteronism.
Stowasser M
J Clin Endocrinol Metab; 2009 Oct; 94(10):3623-30. PubMed ID: 19737921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
